As of 2025-10-20, the Fair Value of Avidity Biosciences Inc (RNA) is -16.78 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 47.89 USD, the upside of Avidity Biosciences Inc is -135.04%.
With the market price of 47.89 USD and our fair value calculation, Avidity Biosciences Inc (RNA) is not a good investment. Investing in Avidity stocks now will result in a potential loss of 135.04%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -44.36 | -118.01 | -174.00 | -212.22 | -322.30 | -174.18 |
| YoY growth | -79.38% | -166.03% | -47.45% | -21.97% | -51.87% | -73.34% |
| Market Cap (mil) | 6,502.50 |
| P/E | |
| Forward P/E |
| EPS | -3.36 |
| Avg earnings growth rate | -73.34% |
| TTM earnings | -455.74 |